Private Trust Company’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$89.9K Buy
+2,092
New +$83.1K 0.01% 1112
2024
Q4
– Sell
-1,063
Closed -$44.6K – 2334
2024
Q3
$44.6K Hold
1,063
– – ﹤0.01% 1182
2024
Q2
$43.4K Hold
1,063
– – ﹤0.01% 1165
2024
Q1
$44.1K Hold
1,063
– – ﹤0.01% 1149
2023
Q4
$43K Hold
1,063
– – 0.01% 1115
2023
Q3
$41.6K Hold
1,063
– – 0.01% 1085
2023
Q2
$43.2K Hold
1,063
– – 0.01% 1086
2023
Q1
$44.5K Hold
1,063
– – 0.01% 1030
2022
Q4
$46K Hold
1,063
– – 0.01% 981
2022
Q3
$41K Hold
1,063
– – 0.01% 958
2022
Q2
$45K Buy
+1,063
New +$46.2K 0.01% 965

Other funds holding BME

Private Trust Company's BME Position: Q2 2026 in Review

Private Trust Company opened a new position in BlackRock Health Sciences Trust (BME) in Q2 2026: 2,092 shares worth $89.9K. The stake represents 0.01% of the portfolio and ranks #1112 among its holdings. This is a return to the name: Private Trust Company previously reported a position in BME as recently as Q3 2024.

Private Trust Company first reported a position in BME in Q2 2022 and has held it in 11 quarters since. 78 funds tracked by Wall St. Rank hold BME as of Q2 2026.

  • Private Trust Company held 2,092 shares of BlackRock Health Sciences Trust worth $89.9K as of Q2 2026.
  • BlackRock Health Sciences Trust was a new Private Trust Company position in Q2 2026.
  • BlackRock Health Sciences Trust made up 0.01% of Private Trust Company's portfolio in Q2 2026, its #1112 holding.
  • Private Trust Company first reported a position in BlackRock Health Sciences Trust in Q2 2022 and has held it in 11 quarters since.
  • 78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.